CD56 expression predicts response to Daratumumab-based regimens.
Blood Cancer J
; 14(1): 62, 2024 Apr 12.
Article
in En
| MEDLINE
| ID: mdl-38609355
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal
Limits:
Humans
Language:
En
Journal:
Blood Cancer J
Year:
2024
Document type:
Article
Affiliation country:
United States